The HPLC Purity Result: What You're Really Looking At
Most research-grade peptide COAs report purity as a percentage derived from high-performance liquid chromatography (HPLC). A typical entry reads: "HPLC Purity: 98.5% (at 214 nm, reverse-phase)." Here's what this means and what to watch for.
What the purity percentage represents
The purity percentage is the area % of the target peptide peak relative to all peaks detected in the HPLC chromatogram. The HPLC instrument separates compounds by their interaction with the column stationary phase and detects them as they elute. The software integrates the area under each peak. If the target peptide peak area is 98.5 out of 100 total peak area units, the reported purity is 98.5%.
This method assumes that all components (peptide and impurities) have similar UV absorbance at the detection wavelength. For most research peptides, this assumption is reasonable: the impurities are typically related peptides or synthesis intermediates that contain similar amino acid sequences and chromophores. However, if an impurity has drastically different UV absorption (e.g., a salt or solvent residue with minimal chromophore), its peak area may underrepresent its mass contribution.
Detection wavelength and why it matters
Research peptides are typically detected at 214 nm or 230 nm—both wavelengths measure absorbance of the peptide backbone (the C=O stretch of amide bonds). Some peptides with aromatic residues (tryptophan, tyrosine, phenylalanine) can be detected at 280 nm, which is more specific to aromatic chromophores.
When comparing COAs from different suppliers, ensure they used the same detection wavelength. If Supplier A reports "98% at 214 nm" and Supplier B reports "97% at 280 nm", they are not directly comparable—the wavelengths measure different chromophoric properties and may yield different purity assessments for the same batch.
What counts as "acceptable" purity?
For research-grade peptides:
- ≥95% HPLC purity—Standard for research use. Appropriate for most in vitro assays.
- ≥98% HPLC purity—High purity. Preferred for quantitative or sensitive assays where trace impurities could introduce confounds.
- <95% HPLC purity—May be acceptable for qualitative work, but investigate the impurity profile (see below). Not recommended for dose-response or quantitative studies.
- Unspecified purity ("Research grade", "99% or higher")—Red flag. Always request the specific, documented purity percentage.
Understanding the Impurity Profile
A COA should describe not just the purity percentage, but also the nature of impurities. A peptide at 96% purity could contain:
- Related peptide impurities—Sequence variants (off-by-one-amino-acid, truncations, extended forms) or isomers. These are expected in peptide synthesis and typically pose minimal research concern if <4% total.
- Water and salts—Residual water (measured separately by Karl Fischer titration) and buffer salts (phosphate, acetate, TFA counterions). These don't pose chemical concerns but can affect molar concentration calculations.
- Organic solvent residues—DMSO, acetonitrile, or other solvents used in purification. If <1%, these are inconsequential. If >2%, they may affect solubility or cellular assays.
- Aggregates or polymers—Higher molecular weight species suggesting peptide dimerization or aggregation. These would appear as later-eluting peaks in reverse-phase HPLC and suggest storage or synthesis issues.
Request that the supplier provide a brief impurity description or, ideally, a copy of the HPLC chromatogram annotating major impurity peaks. If they cannot describe the impurities beyond a single purity percentage, that is a credibility concern.
Mass Spectrometry: Confirming Identity
While HPLC confirms purity, mass spectrometry (MS) confirms chemical identity. The two techniques are complementary:
MALDI-MS and ESI-MS results
Mass spectrometry measures the mass-to-charge ratio (m/z) of peptide ions. For a peptide with known molecular weight, the observed m/z should match the theoretical value (within ±0.1% for high-resolution instruments).
Example: Semaglutide has a theoretical molecular weight of 4,113.58 g/mol. A high-resolution ESI-MS should report m/z values that deconvolute to 4,113.58 ±4 (±1 ppm). If the observed mass is 4,115 or 4,112, that's acceptable. If it's 4,200 or 4,050, something is wrong—either the peptide was mis-synthesized, or the MS instrument requires recalibration.
Multi-charged ions and deconvolution
Electrospray ionization (ESI-MS) often produces multiply charged ions: m/z = (MW + nH)/n, where n is the number of charges. For a 4,000 Da peptide, you might observe peaks at m/z 1,000 (4+ charged), 800 (5+ charged), 667 (6+ charged), etc. Deconvolution software reconstructs the actual mass from these multi-charged peaks. A well-reported COA will include the deconvoluted mass (the actual molecular weight) rather than individual m/z peaks.
Why mass spec matters for modified peptides
For modified peptides (acylated, cyclic, pegylated), mass spectrometry is essential. An HPLC result cannot confirm that:
- An acyl modification (e.g., C18 fatty acid on Semaglutide) is correctly attached. The molecular weight will increase by the mass of the modification. If MW is off, the modification failed or is incomplete.
- A cyclic peptide is truly cyclized. A cyclic form has MW = linear form − 18 (loss of water in the cyclization reaction). If the COA shows the linear MW, the cyclization failed.
- Metal coordination in complexes (e.g., GHK-Cu) is correct. The copper ion adds approximately 64 Da to the theoretical peptide MW. If the observed mass doesn't include this, the copper is missing.
For these peptides, always request mass spectrometry data. HPLC purity alone is insufficient.
Water Content and Lyophilization Quality
Lyophilized peptides should be dry powders. Water content is measured by Karl Fischer titration, a precise method that quantifies trace water in solid samples. A typical COA entry reads: "Water Content: 2.1% w/w (Karl Fischer)."
Interpreting water content
- <2% water—Excellent. The peptide was properly lyophilized and has been stored correctly.
- 2-5% water—Acceptable. Within normal range for well-stored lyophilized peptides.
- 5-10% water—Marginal. Suggests potential lyophilization or storage issues. Investigate supplier storage conditions.
- >10% water—Poor. The peptide may have absorbed moisture during storage or was incompletely lyophilized. Solubility and biological activity may be compromised. Do not use without verification from the supplier.
Excessive water can affect peptide solubility, reduce shelf life, and alter effective concentration calculations. If a supplied peptide shows high water content, request a fresh aliquot or consider an alternative supplier.
Comparing COAs Across Suppliers
When evaluating the same peptide from multiple suppliers, a structured comparison reveals quality differences:
| Metric | Supplier A | Supplier B | Interpretation |
|---|---|---|---|
| HPLC Purity | 98.2% @ 214 nm | 97.5% @ 214 nm | A is slightly higher; both acceptable. If A is consistently higher across batches, suggests better purification process. |
| Molecular Weight (MS) | 4,113.58 ±3 Da | Not provided | B is credibility concern for modified peptide. Always require MS for acylated, cyclic, or metal-complexed peptides. |
| Water Content | 1.8% | 6.2% | A is significantly drier. B's higher water content suggests storage or lyophilization issues. Prefer A. |
| Impurity Description | Related peptide: 1.5%, unidentified: <0.3% | Total impurities: 2.3% (no breakdown) | A provides transparency. B's lack of detail is less informative. Prefer A. |
| Price per mg | $0.85 | $0.42 | B is 50% cheaper. Could indicate lower costs or lower standards. Compare quality metrics; cheaper isn't always better. |
Red Flags: When a COA Should Raise Concerns
- No specific purity percentage. Claims like "High purity" or "99%+" without documented analysis are unacceptable.
- HPLC data but no detection wavelength specified. You cannot assess comparability without knowing the wavelength.
- Mass spectrometry data missing for modified or complex peptides. Unacceptable. Always require MS for acylated, cyclic, or metal-complexed compounds.
- Water content >5% for lyophilized peptides. Suggests storage or lyophilization issues.
- Impurity profile not described or "trace impurities" without detail. Ask for specifics.
- Purity varies dramatically across batches (98%, 94%, 97%, 89%) without explanation. Indicates inconsistent quality control.
- COA lacks date, lot number, or analytical lab contact information. Cannot verify authenticity or request clarification.
- No storage instructions or expiration date. Suggests minimal quality assurance.
Lone Star Peptide Co. provides comprehensive COAs for all in-stock peptides, including purity by reverse-phase HPLC (typically at 214 nm with method details available upon request), water content by Karl Fischer titration, and mass spectrometry confirmation for all modified or complex peptides. All COAs include lot number, manufacture date, water content, storage instructions, and contact information for direct technical questions. Access the full COA library at lonestarpeptideco.com/coa/.
Key Takeaways
Frequently Asked Questions
Disclaimer: This guide is for educational purposes. COA interpretation follows standard analytical chemistry practices for research peptides. Individual assays and institutional policies may require additional quality metrics. Consult your institution's analytical standards for specific requirements.